Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.

We recently compiled a list of the 10 Hottest Smid-Cap Stocks So Far In 2025. In this article, we are going to take a look at ...

Stryker is now opening its pocketbook a bit wider to acquire Inari Medical with its portfolio of blood-clot-busting devices and 1,400 employees. Stryker will put down $80 per share in cash for ...

On Tuesday, Inari Medical Inc (NARI) stock saw a decline, ending the day at $79.5 which represents a decrease of $-0.05 or -0.06% from the prior close of $79.55. The stock opened at $79.54 and touched ...

We recently published an article titled These 10 Firms Led This Week’s Rally. In this article, we are going to take a look at ...

As the name suggests, smid-cap stocks have a valuation between $200 million and $20 billion. The definition is pretty ...

Investing.com -- Inari Medical Inc (NASDAQ ... a condition where blood clots form in veins, as well as other vascular diseases. Stryker will pay $80 per share for Inari, as initially reported ...

Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has a ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from William Blair analyst Margaret Kaczor today. The ...

As such, it's worth looking deeper into each top mid-cap performer. Inari Medical Inc (NASDAQ:NARI) makes medical devices to treat blot clots in veins and their main products are designed to remove ...